NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Crinetics Pharmaceuticals Inc (NASDAQ: CRNX)
CRNX Technical Analysis
1.5
As on 9th Jun 2023 CRNX STOCK Price closed @ 21.67 and we RECOMMEND Buy for LONG-TERM with Stoploss of 20.15 & Sell for SHORT-TERM with Stoploss of 21.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRNXSTOCK Price
Open | 22.42 | Change | Price | % |
High | 22.45 | 1 Day | -0.29 | -1.32 |
Low | 21.60 | 1 Week | -0.43 | -1.95 |
Close | 21.67 | 1 Month | 3.10 | 16.69 |
Volume | 524244 | 1 Year | -2.83 | -11.55 |
52 Week High 28.41 | 52 Week Low 15.31 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
CRNX Daily Charts |
CRNX Intraday Charts |
Whats New @ Bazaartrend |
CRNX Free Analysis |
|
CRNX Important Levels Intraday
RESISTANCE | 23.31 |
RESISTANCE | 22.78 |
RESISTANCE | 22.46 |
RESISTANCE | 22.13 |
SUPPORT | 21.21 |
SUPPORT | 20.88 |
SUPPORT | 20.56 |
SUPPORT | 20.03 |
CRNX Forecast May 2024
4th UP Forecast | 44.7 |
3rd UP Forecast | 37.31 |
2nd UP Forecast | 32.75 |
1st UP Forecast | 28.18 |
1st DOWN Forecast | 15.16 |
2nd DOWN Forecast | 10.59 |
3rd DOWN Forecast | 6.03 |
4th DOWN Forecast | -1.36 |
CRNX Weekly Forecast
4th UP Forecast | 28.72 |
3rd UP Forecast | 26.46 |
2nd UP Forecast | 25.06 |
1st UP Forecast | 23.66 |
1st DOWN Forecast | 19.68 |
2nd DOWN Forecast | 18.28 |
3rd DOWN Forecast | 16.88 |
4th DOWN Forecast | 14.62 |
CRNX Forecast2024
4th UP Forecast | 48.11 |
3rd UP Forecast | 39.63 |
2nd UP Forecast | 34.39 |
1st UP Forecast | 29.15 |
1st DOWN Forecast | 14.19 |
2nd DOWN Forecast | 8.95 |
3rd DOWN Forecast | 3.71 |
4th DOWN Forecast | -4.77 |
Crinetics Pharmaceuticals Inc ( NASDAQ USA Symbol : CRNX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRNX Other Details
Segment | EQ | |
Market Capital | 1173868032.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
CRNX Address
CRNX Latest News
CRNX Business Profile
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 biased agonist that has completed phase II clinical trial for the treatment of acromegaly, as well as completed phase 1 clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist to treat congenital hyperinsulinism, which is in phase 1 clinical trial; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase 1 clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California. Address: Building No. 2, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service